J A Laissue

Summary

Affiliation: University of Bern
Country: Switzerland

Publications

  1. ncbi request reprint Response of the rat spinal cord to X-ray microbeams
    Jean A Laissue
    Institute of Pathology, University of Bern, Switzerland
    Radiother Oncol 106:106-11. 2013
  2. doi request reprint [Alban Köhler (1874-1947): Inventor of grid therapy]
    Jean A Laissue
    Institut für Pathologie der Universität Bern, Murtenstrasse 31, CH 3010 Bern, Schweiz
    Z Med Phys 22:90-9. 2012
  3. doi request reprint Spatial resolution of proton tomography: Methods, initial phase space and object thickness
    Uwe Schneider
    Vetsuisse Faculty, University of Zurich, Zurich, Switzerland
    Z Med Phys 22:100-8. 2012
  4. ncbi request reprint Prospects for microbeam radiation therapy of brain tumours in children to reduce neurological sequelae
    J A Laissue
    Institut für Pathologie der Universität Bern, Bern, Switzerland
    Dev Med Child Neurol 49:577-81. 2007
  5. ncbi request reprint Physics study of microbeam radiation therapy with PSI-version of Monte Carlo code GEANT as a new computational tool
    J Stepanek
    Institute of Pathology, University of Bern, Switzerland
    Med Phys 27:1664-75. 2000
  6. ncbi request reprint Somatostatin receptor sst1-sst5 expression in normal and neoplastic human tissues using receptor autoradiography with subtype-selective ligands
    J C Reubi
    Division of Cell Biology and Experimental Cancer Research, Institute of Pathology, University of Berne, Switzerland
    Eur J Nucl Med 28:836-46. 2001
  7. ncbi request reprint Subcellular distribution of somatostatin sst2A receptors in human tumors of the nervous and neuroendocrine systems: membranous versus intracellular location
    J C Reubi
    Division of Cell Biology and Experimental Cancer Research, Institute of Pathology, University of Berne, Switzerland
    J Clin Endocrinol Metab 85:3882-91. 2000
  8. ncbi request reprint Vasoactive intestinal peptide/pituitary adenylate cyclase-activating peptide receptor subtypes in human tumors and their tissues of origin
    J C Reubi
    Division of Cell Biology and Experimental Cancer Research, Institute of Pathology, University of Berne, Switzerland
    Cancer Res 60:3105-12. 2000
  9. ncbi request reprint Immunohistochemical detection of somatostatin sst2a receptors in the lymphatic, smooth muscular, and peripheral nervous systems of the human gastrointestinal tract: facts and artifacts
    J C Reubi
    Division of Cell Biology and Experimental Cancer Research, Institute of Pathology, University of Berne, Switzerland
    J Clin Endocrinol Metab 84:2942-50. 1999
  10. ncbi request reprint Neurotensin receptors in human neoplasms: high incidence in Ewing's sarcomas
    J C Reubi
    Division of Cell Biology and Experimental Cancer Research, Institute of Pathology, University of Berne, Switzerland
    Int J Cancer 82:213-8. 1999

Detail Information

Publications14

  1. ncbi request reprint Response of the rat spinal cord to X-ray microbeams
    Jean A Laissue
    Institute of Pathology, University of Bern, Switzerland
    Radiother Oncol 106:106-11. 2013
    ..To quantify the late dose-related responses of the rat cervical spinal cord to X-ray irradiations by an array of microbeams or by a single millimeter beam...
  2. doi request reprint [Alban Köhler (1874-1947): Inventor of grid therapy]
    Jean A Laissue
    Institut für Pathologie der Universität Bern, Murtenstrasse 31, CH 3010 Bern, Schweiz
    Z Med Phys 22:90-9. 2012
    ..They could palliate some otherwise intractable malignancies, perhaps in young children too, with tolerable sequelae. There are plans for such studies in larger animals...
  3. doi request reprint Spatial resolution of proton tomography: Methods, initial phase space and object thickness
    Uwe Schneider
    Vetsuisse Faculty, University of Zurich, Zurich, Switzerland
    Z Med Phys 22:100-8. 2012
    ..However, spatial resolution is still a limiting factor and as a consequence experimental methods and image reconstruction should be optimized to improve position resolution...
  4. ncbi request reprint Prospects for microbeam radiation therapy of brain tumours in children to reduce neurological sequelae
    J A Laissue
    Institut für Pathologie der Universität Bern, Bern, Switzerland
    Dev Med Child Neurol 49:577-81. 2007
    ....
  5. ncbi request reprint Physics study of microbeam radiation therapy with PSI-version of Monte Carlo code GEANT as a new computational tool
    J Stepanek
    Institute of Pathology, University of Bern, Switzerland
    Med Phys 27:1664-75. 2000
    ..In contrast Dilmanian-CPE and Persliden-CPE codes deposit the electron energy locally instead of transporting it to the correct position...
  6. ncbi request reprint Somatostatin receptor sst1-sst5 expression in normal and neoplastic human tissues using receptor autoradiography with subtype-selective ligands
    J C Reubi
    Division of Cell Biology and Experimental Cancer Research, Institute of Pathology, University of Berne, Switzerland
    Eur J Nucl Med 28:836-46. 2001
    ..This information is of importance with regard to the clinical applications and development of somatostatin analogues with distinct receptor subtype selectivities...
  7. ncbi request reprint Subcellular distribution of somatostatin sst2A receptors in human tumors of the nervous and neuroendocrine systems: membranous versus intracellular location
    J C Reubi
    Division of Cell Biology and Experimental Cancer Research, Institute of Pathology, University of Berne, Switzerland
    J Clin Endocrinol Metab 85:3882-91. 2000
    ....
  8. ncbi request reprint Vasoactive intestinal peptide/pituitary adenylate cyclase-activating peptide receptor subtypes in human tumors and their tissues of origin
    J C Reubi
    Division of Cell Biology and Experimental Cancer Research, Institute of Pathology, University of Berne, Switzerland
    Cancer Res 60:3105-12. 2000
    ....
  9. ncbi request reprint Immunohistochemical detection of somatostatin sst2a receptors in the lymphatic, smooth muscular, and peripheral nervous systems of the human gastrointestinal tract: facts and artifacts
    J C Reubi
    Division of Cell Biology and Experimental Cancer Research, Institute of Pathology, University of Berne, Switzerland
    J Clin Endocrinol Metab 84:2942-50. 1999
    ....
  10. ncbi request reprint Neurotensin receptors in human neoplasms: high incidence in Ewing's sarcomas
    J C Reubi
    Division of Cell Biology and Experimental Cancer Research, Institute of Pathology, University of Berne, Switzerland
    Int J Cancer 82:213-8. 1999
    ....
  11. ncbi request reprint Receptor autoradiographic evaluation of cholecystokinin, neurotensin, somatostatin and vasoactive intestinal peptide receptors in gastro-intestinal adenocarcinoma samples: where are they really located?
    J C Reubi
    Institute of Pathology, University of Berne, Switzerland
    Int J Cancer 81:376-86. 1999
    ....
  12. ncbi request reprint Neuropathology of ablation of rat gliosarcomas and contiguous brain tissues using a microplanar beam of synchrotron-wiggler-generated X rays
    J A Laissue
    Institute of Pathology, University of Bern, Switzerland
    Int J Cancer 78:654-60. 1998
    ..Correlation of those grades with radiation doses shows that loss of tissue structure was confined to beam-crossing regions and that only minor damage was done to zones of the brain irradiated unidirectionally...
  13. ncbi request reprint MOSFET dosimetry for microbeam radiation therapy at the European Synchrotron Radiation Facility
    E Brauer-Krisch
    European Synchrotron Radiation Facility, B P 220, 38043 Grenoble, France
    Med Phys 30:583-9. 2003
    ..These results lend credence to the use of MOSFET detector systems in edge-on mode for microplanar irradiation dosimetry...
  14. ncbi request reprint Synergy of gene-mediated immunoprophylaxis and microbeam radiation therapy for advanced intracerebral rat 9L gliosarcomas
    H M Smilowitz
    Department of Pharmacology, UCHC, Farmington, CT, USA
    J Neurooncol 78:135-43. 2006
    ..This report, to our knowledge, is the first demonstration that gene-mediated immunotherapy (GMIMPR) enhances the efficacy of MRT for advanced 9LGS tumors...